Company intelligence / Profile preview

Stemulate

Bothell, Washington, United States

Ownership: Private
Development stage: Other

Overview

Biolife Solutions, through its commercial Stemulate platform, provides human platelet lysate-based culture media supplements used globally as a high-performance fetal bovine serum (FBS) replacement in stem cell and immuno-oncology applications, supporting rapid expansion of various cell types including mesenchymal stromal cells, T cells, NK cells, and endothelial cells. The platform is suitable for both research and clinical-grade applications, with products manufactured under an ISO 9001:2015 Quality Management System and available in multiple formats for laboratory and clinical use[1].

Therapeutic areas: OncologyHematologyOther
Modalities: Cell therapy
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Stemulate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stemulate.

Explore the full profile